Juno Therapeutics, Seattle Cancer Care Alliance and Fred Hutchinson Cancer Research Center Announce New Immuno-Oncology Clinical Trials Unit (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)

Juno Therapeutics, Inc., a biopharmaceutical company focused on re-engaging the body's immune system to revolutionize the treatment of cancer, and Fred Hutchinson Cancer Research Center have announced the creation of a new, best-in-class clinical trials unit (CTU) dedicated to immuno-oncology. Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance is one of the 26 NCCN Member Institutions. ...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news